All Stories

  1. Personality and fatal diseases: Revisiting a scientific scandal
  2. Re: Economic comparison of early intervention services with standard care: Flawed model of the costs of homicide
  3. Dietary advice for people with schizophrenia
  4. Use of Denosumab in a Patient with Chronic Anorexia Nervosa and Osteoporosis
  5. Denosumab improves bone density in a female patient with severe anorexia nervosa
  6. Spontaneous Bacterial Peritonitis in a Patient with Anorexia Nervosa with Profound Zinc and Iron Deficiency
  7. Exercise therapy in adults with serious mental illness: a systematic review and meta-analysis
  8. Understanding the problems developing a healthy living programme in patients with serious mental illness: a qualitative study
  9. Survey of patients' view on functional split of consultant psychiatrists
  10. Rational policy making for early psychosis might yet become possible
  11. Dietary advice for schizophrenia
  12. ‘Doing Well’: description of a complex intervention to improve depression care
  13. Comparison of the effectiveness of depot antipsychotics in routine clinical practice
  14. New Alzheimer's disease screening test performs well in UK outpatient settings
  15. Is Treating Patients with First-Episode Psychosis Cost-Effective?
  16. [No Title]
  17. Integrated multidisciplinary diagnostic approach for dementia
  18. Is early intervention in the major psychiatric disorders justified? No
  19. Clinical differences between patients with nonepileptic seizures who report antecedent sexual abuse and those who do not
  20. Donepezil is no more effective than placebo for agitation in people with Alzheimer's disease
  21. A genome-wide linkage study in families with major depression and co-morbid unexplained swelling
  22. Adolescent-onset psychosis: prevalence, needs and service provision
  23. Role of cholinesterase inhibitors in dementia care needs rethinking
  24. Late onset psychogenic nonepileptic attacks
  25. Children in foster care: Mental health, service use and costs
  26. Outcomes of an Early Psychosis Intervention Program
  27. Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia
  28. Dimensions and classes of psychosis in a population cohort: a four-class, four-dimension model of schizophrenia and affective psychoses
  29. Unexplained swelling symptoms in women (idiopathic oedema) comprise one component of a common polysymptomatic syndrome
  30. Value of early intervention in psychosis
  31. Mortality after discharge from long-term psychiatric care in Scotland, 1977 – 94: a retrospective cohort study
  32. Care needs of elderly people with schizophrenia
  33. Is early intervention for psychosis a waste of valuable resources?
  34. Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorder
  35. The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia
  36. Mental health and foster carer training
  37. Review: newer and older antidepressants have similar efficacy and total discontinuation rates but different side effects
  38. Twists in the tale of impossible means
  39. Dilemmas and choices in facing the drugs problem
  40. Intensive case management for severe psychotic illness
  41. Intensive case management for severe psychotic illness
  42. The Fluid Retention Syndrome: Recognition, Risk Factors and Management
  43. Psychotherapy for severe personality disorder: exploring the limits of evidence based purchasing   Commentary: Mix of perspectives needed in purchasing of care
  44. Management of deliberate self poisoning
  45. Review: zuclopenthixol is not more effective than other neuroleptic drugs in the acute treatment of schizophrenia
  46. Prescribing antidepressants in general practice
  47. A population-based incidence study of chronic fatigue
  48. Thyroid function in idiopathic oedema
  49. Computerized assessment of common mental disorders in primary care: effect on clinical outcome
  50. Limitations of psychiatry
  51. Viral illness and chronic fatigue (syndrome)
  52. General practitioners' attitudes to patients with a self diagnosis of myalgic encephalomyelitis
  53. Chronic fatigue syndrome
  54. The role of diuretics in the aetiology of idiopathic oedema
  55. Predictors of chronic "postviral" fatigue
  56. Chronic fatigue syndrome and myaligic encephalomyelitis
  57. Chronic fatigue syndrome: prevalence and outcome
  58. Chronic fatigue in primary care attenders
  59. Familial idiopathic oedema in prepubertal children: a new syndrome
  60. Psychiatric scandals at home and abroad
  61. Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers
  62. Clinical Interview Schedule--Revised
  63. SCIENTIFIC AND ETHICAL PROGRESS IN PSYCHIATRIC GENETICS
  64. Darwin's illness
  65. CLINICAL RESEARCH PLANNING
  66. The work of the Somali Counselling Project in the UK
  67. Acyclovir Treatment of the Chronic Fatigue Syndrome
  68. The computer will see you now.
  69. Ethical Implications of the New Genetics for Psychiatry
  70. Molecular Genetics and Human Disease
  71. Mystical-Ecstatic and Trance States
  72. The development of a computerized assessment for minor psychiatric disorder
  73. MYALGIC ENCEPHALOMYELITIS, OR WHAT?
  74. Postviral fatigue syndrome
  75. Postviral fatigue syndrome: time for a new approach
  76. MORE MAGNETIC RESONANCE SCANNERS?
  77. PSYCHOLOGICAL DISTURBANCES IN IDIOPATHIC OEDEMA
  78. The economics of mental health services.
  79. A PSYCHIATRIC STUDY OF IDIOPATHIC OEDEMA
  80. FROM NAZI HOLOCAUST TO NUCLEAR HOLOCAUST